Boston Scientific company profile

BSX · NYSE · USD

Compare Boston Scientific
$43.03Change from previous close: −1.51%Absolute change: −$0.66

Close · November 17, 2026

Company profile

Boston Scientific has 59,000 employees and is headquartered in Marlborough, United States.

Boston Scientific organizes its medical devices into two segments, MedSurg and Cardiovascular, serving interventional specialties worldwide. The MedSurg range includes gastrointestinal tools such as biliary stent systems and SpyGlass single-use scopes, urological products such as ureteral stents and holmium laser systems, and spinal cord stimulators and deep brain stimulation systems for movement disorders and chronic pain. The Cardiovascular segment offers the WATCHMAN FLX left atrial appendage closure device, cardioverter and cardiac resynchronization therapy defibrillators, pacemakers, insertable cardiac monitors, and devices for peripheral vascular disease and certain cancers. By region, the United States accounts for 64.1% of revenue, followed by EMEA at 17.2% and Asia Pacific at 15.3%.

In the fiscal year ended December 2025, revenue reached 20.1 billion US dollars, up 19.9% from the previous year, and net income came to 2.9 billion US dollars. The company had 59,000 employees and is headquartered in Marlborough, Massachusetts, where it was incorporated in 1979.

Company facts

Industry
Medical Devices
Headquarters
300 Boston Scientific Way, 01752-1234, Marlborough
Employees
59,000
Chief executive
Michael Mahoney
Founded
1979
Fiscal year
January - December
Listing
BSX · NYSE
Indices
S&P 500
Currency
USD
ISIN
US1011371077

Boston Scientific and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Boston ScientificBSXUnited States$63.33B59,00019.6%18.4
Edwards LifesciencesEWUnited States$61.59B16,00028.8%61.6
GE HealthCare TechnologiesGEHCUnited States$37B54,00013.8%17.3
StrykerSYKUnited States$118.29B56,00024.0%33.1
MedtronicMDTUnited States$130.88B95,00020.1%25.1
DexComDXCMUnited States$30.44B11,00024.0%32.1

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Boston Scientific with its competitors